Skip to main content
Cipher Pharmaceuticals Inc. (TSX:CPH)
Canada flag Canada · Delayed Price · Currency is CAD
14.62
-0.54 (-3.56%)
Mar 9, 2026, 2:16 PM EST

Cipher Pharmaceuticals Revenue

Cipher Pharmaceuticals had revenue of $12.83M USD in the quarter ending September 30, 2025, with 23.75% growth. This brings the company's revenue in the last twelve months to $50.06M, up 89.17% year-over-year. In the year 2024, Cipher Pharmaceuticals had annual revenue of $33.36M with 57.66% growth.

Revenue (ttm)
$50.06M
Revenue Growth
+89.17%
P/S Ratio
5.50
Revenue / Employee
$10.01M
Employees
5
Market Cap
383.26M CAD

Revenue Chart

* This company reports financials in USD.

History

Fiscal Year End Revenue Change Growth
Dec 31, 202433.36M12.20M57.66%
Dec 31, 202321.16M487.00K2.36%
Dec 31, 202220.68M-1.27M-5.78%
Dec 31, 202121.94M336.00K1.56%
Dec 31, 202021.61M-844.00K-3.76%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Cresco Labs 899.24M
Aurora Cannabis 373.12M
Organigram Global 279.99M
Verano Holdings 1.16B
TerrAscend 417.11M
Canopy Growth 278.39M
Knight Therapeutics 413.85M
BioSyent 42.18M
Revenue Rankings

Cipher Pharmaceuticals News

More News